Literature DB >> 26156404

Protective immune-response of aluminium hydroxide gel adjuvanted phage lysate of Brucella abortus S19 in mice against direct virulent challenge with B. abortus 544.

Lata Jain1, Mayank Rawat2, Awadhesh Prajapati1, Ashok Kumar Tiwari1, Bablu Kumar3, V K Chaturvedi3, H M Saxena4, Sarvanan Ramakrishnan5, Jatin Kumar1, Priscilla Kerketta6.   

Abstract

The prophylactic efficacies of plain and alum adsorbed lysate were evaluated by direct virulent challenge in mice model. A recently isolated brucellaphage 'ϕLd' was used for generation of lysates. Twenty four h incubated Brucella abortus S19 broth cultures standardized to contain approximately 10(8) CFU/ml were found suitable for generation of lysates. Three lysate batches produced through separate cycles did not show any significant variation with respect to protein and polysaccharide contents, endotoxin level and phage counts, indicating that compositionally stable lysate preparations can be generated through an optimized production process. Three polypeptides of ∼16, 19 and 23 kDa could be identified as immuno-dominant antigens of the lysate which induced both humoral and cell-mediated immune responses in a dose dependent manner. Results of efficacy evaluation trial confirmed dose-dependent protective potencies of lysate preparation. The lysate with an antigenic dose of 0.52 μg protein and 60 μg CHO adsorbed on aluminium gel (0.1 percent aluminium concentration) exhibited the highest protective potency which was greater than that induced by standard S19 vaccine. Phage lysate methodology provides a very viable option through which an improved immunizing preparation with all desirable traits can be developed against brucellosis, and integrated with immunization programmes in a more efficient manner.
Copyright © 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brucellosis; Cell mediate immune response; Humoral response; Phage lysate; Protective efficacy

Mesh:

Substances:

Year:  2015        PMID: 26156404     DOI: 10.1016/j.biologicals.2015.06.006

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  4 in total

1.  Meta-Analysis and Advancement of Brucellosis Vaccinology.

Authors:  Tatiane F Carvalho; João Paulo A Haddad; Tatiane A Paixão; Renato L Santos
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

2.  Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review.

Authors:  Atieh Darbandi; Shabnam Zeighamy Alamdary; Maryam Koupaei; Roya Ghanavati; Mohsen Heidary; Malihe Talebi
Journal:  Front Vet Sci       Date:  2022-09-02

3.  A novel immunotherapy of Brucellosis in cows monitored non invasively through a specific biomarker.

Authors:  Hari Mohan Saxena; Sugandha Raj
Journal:  PLoS Negl Trop Dis       Date:  2018-04-11

4.  Protective role of Brucella abortus specific murine antibodies in inhibiting systemic proliferation of virulent strain 544 in mice and guinea pig.

Authors:  Suman Verma; Mayank Rawat; Sanjay Kumawat; Salauddin Qureshi; Gulam Mohd; Ashok Kumar Tiwari
Journal:  Vet World       Date:  2018-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.